Ray Taylor
Impact in
- Infectious Diseases top 10%
- Viral Infections and Vectors
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- COVID-19 Clinical Research Studies
-
- Mosquito-borne diseases and control
- Malaria Research and Control
Papers in
-
- Viral Infections and Vectors 7
- Viral Infections and Outbreaks Research 5
- SARS-CoV-2 and COVID-19 Research 2
- Viral gastroenteritis research and epidemiology 1
-
- Mosquito-borne diseases and control 5
- Co-authors
- Amanda Mathis (8 shared papers)William Sheridan (7 shared papers)Y.S. Babu (5 shared papers)Justin G. Julander (2 shared papers)Brian B. Gowen (2 shared papers)Dennis M. Walling (3 shared papers)James F. Demarest (2 shared papers)John D. Morrey (1 shared paper)
- Journals
- Antiviral Research (3 papers)Open Forum Infectious Diseases (3 papers)Science Translational Medicine (1 paper)Viruses (1 paper)Clinical Pharmacology in Drug Development (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Ray Taylor
9 papers receiving 295 citations
Peers
Comparison fields: 5 of 46
- Infectious Diseases 238
- Public Health, Environmental and Occupational Health 136
- Modeling and Simulation 15
- Virology 10
- Insect Science 23
Countries citing papers authored by Ray Taylor
This map shows the geographic impact of Ray Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Taylor more than expected).
Fields of papers citing papers by Ray Taylor
This network shows the impact of papers produced by Ray Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Taylor. The network helps show where Ray Taylor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ray Taylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 127 | |
| 2 | 2018 | 54 | |
| 3 | 2021 | 53 | |
| 4 | 2020 | 20 | |
| 5 | 2021 | 14 | |
| 6 | 2017 | 12 | |
| 7 | 2017 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2016 | 5 |
About Ray Taylor
Ray Taylor is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Health and Global and Planetary Change, having authored 9 papers that have together received 305 indexed citations. Recurring topics across this work include Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (5 papers), Mosquito-borne diseases and control (5 papers), Virology and Viral Diseases (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Fire effects on ecosystems (1 paper), Vaccine Coverage and Hesitancy (1 paper) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Infectious Diseases (238 citations), Public Health, Environmental and Occupational Health (136 citations), Modeling and Simulation (15 citations), Virology (10 citations) and Insect Science (23 citations). Ray Taylor has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Amanda Mathis, William Sheridan, Y.S. Babu, Justin G. Julander, Brian B. Gowen, Dennis M. Walling, James F. Demarest, John D. Morrey, Young-Min Lee and Makda S. Gebre. Their work appears in journals such as Antiviral Research, Open Forum Infectious Diseases, Science Translational Medicine, Viruses and Clinical Pharmacology in Drug Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.